Trial · NCT03434028
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Death Before Discharge Home by Day 90 | From randomization to discharge home up to and including day 90. | There were 109 deaths and 5 patients with censored data the restrictive fluid group. There were 116 deaths and 4 patients with censored data in the liberal group. Point estimates from the Kaplan-Meier curve. | percentage of participants | NUMBER |
| SECONDARY | Organ Support Free Days | 28 days after randomization | We only report primary and secondary outcomes using available data without imputation. Because of missing data, the denominator may vary for selected outcomes as reported in the primary publication (PMID: 36688507). | days | MEAN |
| SECONDARY | Ventilator Free Days (VFD) | 28 days after randomization | days | MEAN | |
| SECONDARY | Renal Replacement Free Days | 28 days after randomization | days | MEAN | |
| SECONDARY | Vasopressor Free Days | From study day 2 through day 28 | days | MEAN | |
| SECONDARY | ICU Free Days | 28 days after randomization | days | MEAN | |
| SECONDARY | Hospital Free Days to Discharge Home | 28 days after randomization | days | MEAN | |
| SECONDARY | New Intubation With Invasive Mechanical Ventilation by 28 Days | 28 days after randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Initiation of Renal Replacement Therapy | 28 days after randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Kidney Disease: Change in Creatinine-based Global Outcomes (KIDGO) Score Between Baseline and 72 Hours | 72 hours after randomization | score on a scale | MEAN | |
| SECONDARY | Change in SOFA (Sepsis Related Organ Failure Assessment) Score | 72 hours after randomization | score on a scale | MEAN | |
| SECONDARY | Development of ARDS | 7 days after randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | New Onset Atrial or Ventricular Arrhythmia | 28 days after randomization | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Death From Any Cause at Any Location by Day 90 | From randomization to and including day 90 | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03434028/outcomes